My research interest lies in particle technology, pharmaceutical engineering, computational mechanics, and numerical modelling and simulations. I am currently leading a research group focusing on predictive modeling of particle systems and two-phase flows. I have been collaborating with global pharmaceutical companies including Pfizer, AstraZeneca and Sanofi Aventis on the application of advanced computational modeling, including finite element methods, discrete element methods and computational fluid dynamics, and experimental techniques, such as Positron Emission Particle Tracking (PEPT), X-ray micro-computed tomography and nano-indentation, in exploring the fundamental particle science ranging from particle-particle interaction to macroscopic behaviour of particulate systems.